The structure of dimeric ROCK I reveals the mechanism for ligand selectivity - PubMed (original) (raw)
. 2006 Jan 6;281(1):260-8.
doi: 10.1074/jbc.M508847200. Epub 2005 Oct 24.
Affiliations
- PMID: 16249185
- DOI: 10.1074/jbc.M508847200
Free article
The structure of dimeric ROCK I reveals the mechanism for ligand selectivity
Marc Jacobs et al. J Biol Chem. 2006.
Free article
Abstract
ROCK or Rho-associated kinase, a serine/threonine kinase, is an effector of Rho-dependent signaling and is involved in actin-cytoskeleton assembly and cell motility and contraction. The ROCK protein consists of several domains: an N-terminal region, a kinase catalytic domain, a coiled-coil domain containing a RhoA binding site, and a pleckstrin homology domain. The C-terminal region of ROCK binds to and inhibits the kinase catalytic domains, and this inhibition is reversed by binding RhoA, a small GTPase. Here we present the structure of the N-terminal region and the kinase domain. In our structure, two N-terminal regions interact to form a dimerization domain linking two kinase domains together. This spatial arrangement presents the kinase active sites and regulatory sequences on a common face affording the possibility of both kinases simultaneously interacting with a dimeric inhibitory domain or with a dimeric substrate. The kinase domain adopts a catalytically competent conformation; however, no phosphorylation of active site residues is observed in the structure. We also determined the structures of ROCK bound to four different ATP-competitive small molecule inhibitors (Y-27632, fasudil, hydroxyfasudil, and H-1152P). Each of these compounds binds with reduced affinity to cAMP-dependent kinase (PKA), a highly homologous kinase. Subtle differences exist between the ROCK- and PKA-bound conformations of the inhibitors that suggest that interactions with a single amino acid of the active site (Ala215 in ROCK and Thr183 in PKA) determine the relative selectivity of these compounds. Hydroxyfasudil, a metabolite of fasudil, may be selective for ROCK over PKA through a reversed binding orientation.
Similar articles
- Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity.
Breitenlechner C, Gassel M, Hidaka H, Kinzel V, Huber R, Engh RA, Bossemeyer D. Breitenlechner C, et al. Structure. 2003 Dec;11(12):1595-607. doi: 10.1016/j.str.2003.11.002. Structure. 2003. PMID: 14656443 - Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil.
Yamaguchi H, Kasa M, Amano M, Kaibuchi K, Hakoshima T. Yamaguchi H, et al. Structure. 2006 Mar;14(3):589-600. doi: 10.1016/j.str.2005.11.024. Structure. 2006. PMID: 16531242 - Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.
Heikkila T, Wheatley E, Crighton D, Schroder E, Boakes A, Kaye SJ, Mezna M, Pang L, Rushbrooke M, Turnbull A, Olson MF. Heikkila T, et al. PLoS One. 2011;6(9):e24825. doi: 10.1371/journal.pone.0024825. Epub 2011 Sep 20. PLoS One. 2011. PMID: 21949762 Free PMC article. - Rho kinase as a therapeutic target in cardiovascular disease.
Surma M, Wei L, Shi J. Surma M, et al. Future Cardiol. 2011 Sep;7(5):657-71. doi: 10.2217/fca.11.51. Future Cardiol. 2011. PMID: 21929346 Free PMC article. Review. - Structural insights into AGC kinase inhibition.
Breitenlechner C, Gassel M, Engh R, Bossemeyer D. Breitenlechner C, et al. Oncol Res. 2004;14(6):267-78. doi: 10.3727/096504003773994806. Oncol Res. 2004. PMID: 15206489 Review.
Cited by
- Design and synthesis of novel 8-(azaindolyl)-benzoazepinones as potent and selective ROCK inhibitors.
Pala D, Clark D, Edwards C, Pasqua E, Tigli L, Pioselli B, Malysa P, Facchinetti F, Rancati F, Accetta A. Pala D, et al. RSC Med Chem. 2024 Sep 16. doi: 10.1039/d4md00313f. Online ahead of print. RSC Med Chem. 2024. PMID: 39297059 Free PMC article. - ROCK and the actomyosin network control biomineral growth and morphology during sea urchin skeletogenesis.
Hijaze E, Gildor T, Seidel R, Layous M, Winter M, Bertinetti L, Politi Y, Ben-Tabou de-Leon S. Hijaze E, et al. Elife. 2024 Apr 4;12:RP89080. doi: 10.7554/eLife.89080. Elife. 2024. PMID: 38573316 Free PMC article. - The Magic Methyl and Its Tricks in Drug Discovery and Development.
Pinheiro PSM, Franco LS, Fraga CAM. Pinheiro PSM, et al. Pharmaceuticals (Basel). 2023 Aug 15;16(8):1157. doi: 10.3390/ph16081157. Pharmaceuticals (Basel). 2023. PMID: 37631072 Free PMC article. Review. - Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk.
Qin K, Yu M, Fan J, Wang H, Zhao P, Zhao G, Zeng W, Chen C, Wang Y, Wang A, Schwartz Z, Hong J, Song L, Wagstaff W, Haydon RC, Luu HH, Ho SH, Strelzow J, Reid RR, He TC, Shi LL. Qin K, et al. Genes Dis. 2023 Mar 24;11(1):103-134. doi: 10.1016/j.gendis.2023.01.030. eCollection 2024 Jan. Genes Dis. 2023. PMID: 37588235 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases